tiprankstipranks
Enzychem Lifesciences Corp. (KR:183490)
:183490
South Korea Market
183490
Enzychem Lifesciences Corp.
RESEARCH TOOLSreports

Enzychem Lifesciences Corp. (183490) Financial Statements

― Followers

Enzychem Lifesciences Corp. Financial Overview

Enzychem Lifesciences Corp.'s market cap is currently ₩76.86B. The company's EPS TTM is ₩-233.3; its P/E ratio is -7.33; Enzychem Lifesciences Corp. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 67.75B₩ 77.38B₩ 76.04B₩ 26.64B₩ 22.98B
Gross Profit₩ 3.38B₩ 4.31B₩ 4.35B₩ 2.42B₩ 286.72M
Operating Income₩ -13.09B₩ -13.19B₩ -14.36B₩ -14.66B₩ -20.75B
EBITDA₩ -14.90B₩ -18.39B₩ -5.75B₩ -13.16B₩ -17.89B
Net Income₩ -18.13B₩ -22.11B₩ -9.33B₩ -25.09B₩ -27.86B
Balance Sheet
Cash & Short-Term Investments₩ 92.82B₩ 117.07B₩ 137.35B₩ 192.86B₩ 94.59B
Total Assets₩ 148.59B₩ 181.74B₩ 211.55B₩ 247.55B₩ 133.08B
Total Debt₩ 4.84B₩ 4.88B₩ 5.66B₩ 37.78B₩ 51.98B
Net Debt₩ -3.00B₩ -5.42B₩ -9.81B₩ 30.10B₩ 49.19B
Total Liabilities₩ 9.83B₩ 20.26B₩ 16.92B₩ 45.81B₩ 58.42B
Stockholders' Equity₩ 137.54B₩ 160.35B₩ 193.52B₩ 201.74B₩ 74.66B
Cash Flow
Free Cash Flow₩ -11.79B₩ -1.06B₩ -12.56B₩ -22.33B₩ -24.47B
Operating Cash Flow₩ -11.01B₩ -573.93M₩ -10.26B₩ -14.32B₩ -18.59B
Investing Cash Flow₩ 11.93B₩ 7.36B₩ 53.56B₩ -109.23B₩ -9.73B
Financing Cash Flow₩ -3.34B₩ -12.14B₩ -35.50B₩ 128.50B₩ 29.26B
Currency in KRW

Enzychem Lifesciences Corp. Earnings and Revenue History

Income Statement >

Enzychem Lifesciences Corp. Debt to Assets

Balance Sheet >

Enzychem Lifesciences Corp. Cash Flow

Cash Flow >

Enzychem Lifesciences Corp. Forecast EPS vs Actual EPS

Earnings >